Literature DB >> 3172276

Serum contains inducers and repressors of oligodendrocyte differentiation.

L Bologa1, R Cole, F Chiappelli, R P Saneto, J de Vellis.   

Abstract

An important stage in oligodendrocyte development is the expression of galactocerebroside (GC), the major glycolipid in myelin. Although oligodendrocyte cell lineage and differentiation in vitro have been the object of many studies, to date there is sparse information on the regulation of GC expression in oligodendrocytes already committed to be positive for GC. We report here that GC expression in these cells is controlled by three serum factors. Two of these, possibly a lipoprotein and a mucoprotein, increase GC levels, whereas the third, probably a glycoprotein, exerts an inhibitory effect. The developmental increase of GC in postnatal rat brain cerebral cultures and its induction by serum factors are reversible phenomena. The isolation of the GC-regulatory factors would allow experimental manipulation of impaired GC expression by differentiated oligodendrocytes.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3172276     DOI: 10.1002/jnr.490200206

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  4 in total

1.  Schwann cell survival mediated by the signaling phospholipid lysophosphatidic acid.

Authors:  J A Weiner; J Chun
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

2.  Early and late passage C-6 glial cell growth: similarities with primary glial cells in culture.

Authors:  D Mangoura; N Sakellaridis; J Jones; A Vernadakis
Journal:  Neurochem Res       Date:  1989-10       Impact factor: 3.996

3.  Cellular interactions and oligodendrocyte differentiation in vitro.

Authors:  G Levi; C Agresti
Journal:  Cytotechnology       Date:  1991-02       Impact factor: 2.058

4.  Human oligodendrocytes in dissociated cell culture.

Authors:  F Rihs; J Kesselring; C Meier
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.